HSPs themselves can be prognostic factors in breast cancer and especially oncogenic properties of HSP90AA1 correlated with aggressive clinicopathological features and resistance to the treatment (Whitesell et al., 2014; Klimczak et al., 2019). The gene discussed is HSP90AA1; the disease is breast carcinoma.